This infrastructure-level integration signals growing validation of NurseMagic™ as a scalable EMR solution in non-acute care. Traders should monitor next quarterly revenue trends for sustained growth and potential customer conversion from the integrated platform network.
Price Chart
Executive Summary
Amesite Inc. announced an Electronic Transactions Trading Partner Agreement with a major homecare technology platform, enabling its AI-native NurseMagic™ EMR to integrate with established CMS-compliant electronic visit verification (EVV) systems. This allows seamless adoption by homecare providers without workflow disruption, supporting scalable deployment across the $1.55 trillion non-acute care market.
Key Financial Metrics
Key Facts
- Amesite entered into a HIPAA-compliant trading partner agreement with a leading homecare tech platform processing tens of billions in annual services.
- NurseMagic™ is now authorized to connect securely to a national electronic transaction infrastructure for EVV compliance under CMS and 21st Century Cures Act standards.
- Integration enables providers using the larger platform to adopt NurseMagic™'s AI workflows without changing existing EVV processes.
- Company highlighted recent momentum: 69% QoQ revenue growth in Q2 2026, 63% revenue growth post-enterprise model launch, and prior 140% quarterly increase.
- NurseMagic™ named finalist for Nurse.org’s 'Best of Nursing: AI Nursing Tool' award; CEO recognized by McKnight’s.
Financial Impact
Revenue growth momentum continues with 69% QoQ increase in Q2 2026 and 63% growth following enterprise subscription model launch
Risk Factors
- Forward-looking statements carry inherent uncertainty; actual adoption may lag expectations.
- Dependence on third-party platforms for distribution could limit pricing power or customization.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3263190 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 14, 2026 12d ago | DEFA14A | $0.8825 | awaiting T+60 | — | $0.6000 (−32.01%) |
Oct 14, 2026 12d ago | DEF 14A | $0.8825 | awaiting T+60 | — | $0.6000 (−32.01%) |
Jun 3, 2026 20w ago | DEFA14A | $1.39 $1.06 | ▼ −23.74% | ▼ −25.62% | $0.6000 (−56.83%) |
May 29, 2026 21w ago | EFFECT | $1.41 $1.16 | ▲ +17.73% | ▲ +18.91% | $0.6000 (+57.45%) |
May 19, 2026 22w ago | 8-K | $1.73 $1.07 | ▼ −38.15% | ▼ −44.44% | $0.6000 (−65.32%) |
May 12, 2026 23w ago | S-1 | $0.8310 $1.05 | ▼ −26.35% | ▼ −21.92% | $0.6000 (+27.80%) |
Apr 28, 2026 25w ago | 424B5 | $0.9800 $0.9519 | ▲ +2.87% | ▲ +6.86% | $0.6000 (+38.78%) |
Apr 27, 2026 26w ago | Press Release | $1.05 $0.9802 | ▲ +6.65% | ▲ +11.42% | $0.6000 (+42.86%) |
Apr 27, 2026 26w ago | Press Release | $1.05 $0.9802 | ▼ −6.65% | ▼ −11.42% | $0.6000 (−42.86%) |
Apr 20, 2026 27w ago | S-1 | $1.30 $1.05 | ▲ +19.23% | ▲ +26.13% | $0.6000 (+53.85%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers